Search Results Search Sort by RelevanceMost Recent Case and Commentary Nov 2017 Should Health Care Organizations Use Information Gleaned from Organization-Sponsored Patient Support Groups in Strategic Planning? Priya Nambisan, PhD The risks of misinformation being spread through online patient forums can be mitigated by communication strategies aimed at physicians and organizations. AMA J Ethics. 2017;19(11):1088-1095. doi: 10.1001/journalofethics.2017.19.11.ecas3-1711. Case and Commentary Aug 2021 How Should Willingness-to-Pay Values of Quality-Adjusted Life-Years Be Updated and According to Whom? Paul T. Menzel, PhD Justification for using WTP values and QALYs lies in incorporating preferences of those whose treatment could be affected. AMA J Ethics. 2021;23(8):E601-606. doi: 10.1001/amajethics.2021.601. Policy Forum Aug 2021 How Does Cost-Effectiveness Analysis Inform Health Care Decisions? David D. Kim, PhD and Anirban Basu, PhD CEA has been increasingly used to inform public and private organizations’ reimbursement decisions, benefit designs, and price negotiations worldwide. AMA J Ethics. 2021;23(8):E639-647. doi: 10.1001/amajethics.2021.639. Case and Commentary Nov 2017 What Should Leaders Do When Inefficiency Is Perceived as a Cost of Inclusivity in Strategic Planning Processes in Health Care? Aveena Kochar, MD and Alia Chisty, MS, MD Commentary by Aveena Kochar, MD, and Alia Chisty, MS, MD Co-creative teams can overcome conflict by drawing on quality improvement principles. AMA J Ethics. 2017;19(11):1081-1087. doi: 10.1001/journalofethics.2017.19.11.ecas2-1711. Case and Commentary Sep 2020 How Should Clinicians’ Performance Be Assessed When Health Care Organizations Implement Behavioral Architecture That Generates Negative Consequences? Safiya Richardson, MD, MPH Interventions’ influences on decision making situate clinician performance evaluations in key ways. AMA J Ethics. 2020;22(9):E760-766. doi: 10.1001/amajethics.2020.760. Case and Commentary Oct 2022 What Would It Mean for Health Care Organizations to Justly Manage Their Waste? Genevieve S. Silva and Cassandra Thiel, PhD Restructuring health care waste management involves making existing waste audit data transparent. AMA J Ethics. 2022;24(10):E934-943. doi: 10.1001/amajethics.2022.934. Case and Commentary Nov 2016 Requests for VIP Treatment in Pathology: Implications for Social Justice and Systems-Based Practice Virginia Sheffield and Lauren B. Smith, MD Preferential treatment of “very important” patients is not only unjust but also can compromise patient safety, which is overlooked in medical ethics. AMA J Ethics. 2016;18(8):786-792. doi: 10.1001/journalofethics.2016.18.8.ecas4-1608. Medicine and Society Apr 2024 Mapping a Way to Displaced Persons’ Access to Quality Medicines Carly Ching, PhD and Muhammad H. Zaman, PhD Reliable supply of quality-assured medicines is hard to maintain in refugee camps in low- and middle-income countries with conflict zones. AMA J Ethics. 2024;26(4):E341-347. doi: 10.1001/amajethics.2024.341. Case and Commentary Apr 2024 How Should Regulators and Manufacturers Prevent Avoidable Deaths of Children From Contaminated Cough Syrup? Kavitha Nallathambi, MPH, MBA and Amy B. Cadwallader, PhD Quality control testing is ethically and clinically key to increasing transparency in excipient supply chains. AMA J Ethics. 2024;26(4):E289-294. doi: 10.1001/amajethics.2024.289. Podcast Apr 2024 Ethics Talk: Supply Chain Reasons Your Pharmacy Might Not Have Your Medicine Dr Amy B. Cadwallader joins Ethics Talk to discuss how critical medicine supply chains are identified and secured. Pagination Current page 1 Page 2 Next page Next › Last page Last »
Case and Commentary Nov 2017 Should Health Care Organizations Use Information Gleaned from Organization-Sponsored Patient Support Groups in Strategic Planning? Priya Nambisan, PhD The risks of misinformation being spread through online patient forums can be mitigated by communication strategies aimed at physicians and organizations. AMA J Ethics. 2017;19(11):1088-1095. doi: 10.1001/journalofethics.2017.19.11.ecas3-1711.
Case and Commentary Aug 2021 How Should Willingness-to-Pay Values of Quality-Adjusted Life-Years Be Updated and According to Whom? Paul T. Menzel, PhD Justification for using WTP values and QALYs lies in incorporating preferences of those whose treatment could be affected. AMA J Ethics. 2021;23(8):E601-606. doi: 10.1001/amajethics.2021.601.
Policy Forum Aug 2021 How Does Cost-Effectiveness Analysis Inform Health Care Decisions? David D. Kim, PhD and Anirban Basu, PhD CEA has been increasingly used to inform public and private organizations’ reimbursement decisions, benefit designs, and price negotiations worldwide. AMA J Ethics. 2021;23(8):E639-647. doi: 10.1001/amajethics.2021.639.
Case and Commentary Nov 2017 What Should Leaders Do When Inefficiency Is Perceived as a Cost of Inclusivity in Strategic Planning Processes in Health Care? Aveena Kochar, MD and Alia Chisty, MS, MD Commentary by Aveena Kochar, MD, and Alia Chisty, MS, MD Co-creative teams can overcome conflict by drawing on quality improvement principles. AMA J Ethics. 2017;19(11):1081-1087. doi: 10.1001/journalofethics.2017.19.11.ecas2-1711.
Case and Commentary Sep 2020 How Should Clinicians’ Performance Be Assessed When Health Care Organizations Implement Behavioral Architecture That Generates Negative Consequences? Safiya Richardson, MD, MPH Interventions’ influences on decision making situate clinician performance evaluations in key ways. AMA J Ethics. 2020;22(9):E760-766. doi: 10.1001/amajethics.2020.760.
Case and Commentary Oct 2022 What Would It Mean for Health Care Organizations to Justly Manage Their Waste? Genevieve S. Silva and Cassandra Thiel, PhD Restructuring health care waste management involves making existing waste audit data transparent. AMA J Ethics. 2022;24(10):E934-943. doi: 10.1001/amajethics.2022.934.
Case and Commentary Nov 2016 Requests for VIP Treatment in Pathology: Implications for Social Justice and Systems-Based Practice Virginia Sheffield and Lauren B. Smith, MD Preferential treatment of “very important” patients is not only unjust but also can compromise patient safety, which is overlooked in medical ethics. AMA J Ethics. 2016;18(8):786-792. doi: 10.1001/journalofethics.2016.18.8.ecas4-1608.
Medicine and Society Apr 2024 Mapping a Way to Displaced Persons’ Access to Quality Medicines Carly Ching, PhD and Muhammad H. Zaman, PhD Reliable supply of quality-assured medicines is hard to maintain in refugee camps in low- and middle-income countries with conflict zones. AMA J Ethics. 2024;26(4):E341-347. doi: 10.1001/amajethics.2024.341.
Case and Commentary Apr 2024 How Should Regulators and Manufacturers Prevent Avoidable Deaths of Children From Contaminated Cough Syrup? Kavitha Nallathambi, MPH, MBA and Amy B. Cadwallader, PhD Quality control testing is ethically and clinically key to increasing transparency in excipient supply chains. AMA J Ethics. 2024;26(4):E289-294. doi: 10.1001/amajethics.2024.289.
Podcast Apr 2024 Ethics Talk: Supply Chain Reasons Your Pharmacy Might Not Have Your Medicine Dr Amy B. Cadwallader joins Ethics Talk to discuss how critical medicine supply chains are identified and secured.